- Report
- March 2024
- 194 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- January 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1442EUR$1,500USD£1,237GBP
- Report
- February 2021
- 500 Pages
United States
From €2308EUR$2,400USD£1,980GBP
- Report
- February 2024
- 70 Pages
India
From €4567EUR$4,750USD£3,918GBP
- Report
- November 2020
- 225 Pages
Global
From €10572EUR$10,995USD£9,069GBP
- Report
- May 2024
- 50 Pages
Global
From €2548EUR$2,650USD£2,186GBP
Bromocriptine is a drug used to treat endocrine and metabolic disorders. It is a dopamine agonist, meaning it works by activating dopamine receptors in the body. It is used to treat conditions such as acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders. Bromocriptine is available in both oral and injectable forms.
Bromocriptine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders.
Some companies in the Bromocriptine market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more
